Nymox Pharmaceutical Corp (NYMXF)

[keekee]

Lol. They waited for fast traders to sell and now headed up. If it maintains this momo you'd see $7 here with the shorts struggling and tweeting...they may not have covered much in belief that the tweets would bring the stock back. But seems like they are facing a more determined enemy

[cjstocksup]

This news is HUGE. NYMX should continue to rise now that most profit takers left yesterday and this AM leaving most of the float held tightly on the news. It would not surprise me to see a nice steady climb the rest of the day. I would love to break this AM's ore market highs over $6.00 later today!

[WannaBeFortuneSeller]

It feels like 200M$ valuation at 5$ stock price seems like a steal for some big pharma buyout. This could be anything now because 10$ is just 400M$ valuation.

[NotRichYet2]

Profit takers active now which is actually good in setting up a bottom for the next upswing. Should now view NYMX on where it will go longer than a day or two. FDA approval will come but not for awhile.

[keekee]

Google this about Adam and his gang. Investors should make him bankrupt and not enrich him: "Adam Feuerstein has been writing for the Street.com since 2001 and is marketed as their Senior Columnist although he has never attended journalism school nor does he have any formal education in Journalism. In fact, he has NO formal science background either (he was a political science major at Emory University) and thus his credibility and objectivity as a biotech journalist must be questioned. He has been sued by biotech companies for his one sided attacks ."

[declaes]

Are there really people that still listen to Adem F.? No way. He has a 80% wrong rate. There aren't many doing worse.

[NotRichYet2]

That would make the FEB 2017 CALL options a steal right now should it go there

[keekee]

Adam said drug is zero but it seems like he and his gang are losing their pants on this one. Every day is for the thief but one day is for the real owner. That day the thief pays for all.

[RISK-TAKER]

Good estimate...guessing teens..

[NotRichYet2]

So any GUESSES or ESTIMATES as to what this company can be worth AFTER FDA approval. Over $10 would seem resonable. TIA

[cjstocksup]

NYMX is on fire again today! Waiting to see what they do on the market open but pre market was insane. Could see some profit taking on the open a bit lower than this range before the next leg up again. This is a huge gap and runner this AM.

[ming1234]

can we have another squeeze today?

[ClearlyStocks]

It went $6.12

[stockinvestor56]

What did Adam say? Sorry I don't have twitter.

[NotRichYet2]

PPS now bouncing both UP and DOWN. Guessing next REAL up move comes with FDA approval , partnership , or buyout. Day trader haven till then.

[2fer1]

This may run a couple days. The news was pretty strong.

[keekee]

This might still go to $6 because of the heavy shorting. That's why Adam had to wake up to tweet.... because the heat of heavy losses was all over him

[keekee]

Some brokers let you start by 7 like Fidelity

[ejtamayo]

How are you able to trade at this time?

[RISK-TAKER]

112k shares and $5.60 pre market..

[keekee]

Out $5.75. good luck to all

[ClearlyStocks]

$6.12

[ClearlyStocks]

$6.05

[ClearlyStocks]

$5.90 boom boom

[Yo-Yo]

$5.90 wow congrats to all!!!

[ClearlyStocks]

$5.37

[RISK-TAKER]

Positive U.S. phase 3 data,approval in the next 2 quarters ..
More shorts mean more fuel..how do u think those $3 shorts are liking it?
But I do have to say thanks to one that allowed me to buy under two bucks ..
Thanks dumb ass.. ;)

[2014turnaround]

When claytrader is around naked shorts are around look at EBI* 10.00-.20-5.00,ELT* .38-.11.-.16 and so many more that just freefall!

[crudeoil24]

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce successful new study results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials for fexapotide, the Company's lead compound in late stage development for enlarged prostate (BPH) and for localized prostate cancer. The aim of the study was to determine the clinical benefit fexapotide can provide to men who initially were double blind randomized to and received placebo, remained blinded as to their placebo treatment, and who subsequently required additional medical and/or surgical treatment. In the new study long-term outcomes were determined in 391 patients who were given double blind placebo injections, which were followed by crossover to other treatments at the patients' discretion. The numbers of blinded placebo patients who subsequently received surgical treatment during the next 2-3 years for their BPH symptoms were then prospectively analyzed. Results have now shown that there was 82-95% reduction in the number of these patients who required surgery after they received crossover fexapotide in the trial, as compared to patients who did not receive fexapotide but instead received crossover conventional approved BPH treatments (p<.0001).
“These exciting results from this long-term prospective analysis confirm what I and other researchers have consistently seen in the clinic -- that it is obvious that fexapotide greatly helps patients in terms of symptomatic benefit for their BPH; and with these results, the clinical benefit also results in much less need for surgical intervention over the long-term. I believe these clinical results, combined with previously reported incidence and progression of prostate cancer in this patient population are truly important. Furthermore, the extreme safety of this new drug and the lack of sexual side effects are remarkably helpful for patients,” said Dr. Mo Bidair, Medical Director of San Diego Clinical Trials in San Diego, CA and an Investigator who has participated for many years in the Fexapotide Clinical Trials.

[easymoney]

I will tomorrow maybe.

[Sibware]

NYMX: 527K shares traded a/h till now

[Wesley1961]

can you finish your post?

[easymoney]

Think tomorrow am maybe

[keekee]

Amazing that shorts just sat on the shares for two weeks waiting to be grilled this way. This may see $6 before it cools.

[easymoney]

Short squeeze!!

[ClearlyStocks]

$5.13

[ClearlyStocks]

$5.02

[easymoney]

Yep 5.04 will do it.

[MIKE2OO5]

Finally shorters have been caught!!!

[AXE_EVERYTHING]

$5.50 can happen in AH

[ClayTrader]

* * $NYMX Video Chart 08-24-16 * *

Link to Video - click here to watch the technical chart video

[ClearlyStocks]

$4.94, guess $5 coming before tomorrow.

[ClearlyStocks]

$4.80 wow. $5+ p/m tomorrow?

[ClearlyStocks]

$4.58 wow

[2fer1]

The results..."clearly demonstrate that fexapotide reduces the long-term need for surgery by 82-95% compared to approved conventional BPH treatments”. This quote says it all. IMO

[2fer1]

This will Gap up in the AM.

[ClearlyStocks]

$4.45

[ClearlyStocks]

$4.40

[PENNIEStoSTACKS]

$10 Coming ?

[RISK-TAKER]

Small float...after today's news and run..I'm thinking $$ teens $$ soon..
G/L